If you or a loved on has cancer, you may want to think about taking part in a clinical trial. We often have early access to promising anti-cancer drugs and drug combinations, radiation therapies and surgical techniques.
On average, there are 60 cancer research studies open and available to cancer patients at MultiCare. We also conduct our own research programs that include clinical trials of investigational medications that are not yet commercially available.
Patients can enter clinical trials before, during, or after starting their cancer treatment. Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.
- New Treatments in Clinical Trials
- Clinical trials are one of the final steps in a long research process. Before new treatments are used in research studies involving people, they are tested in labs or on animals. Once people are involved, they are called clinical trials. Most clinical trials go through a series of phases:
- Phase I Trials – done to find a safe dose, how to give the new treatment, and to see how it affects humans.
- Phase II Trials – sees if the new treatment has an effect on a certain cancer. These trials also see how the new treatment affects the human body.
- Phase III Trials – compares the new treatment with the currently prescribed standard of care.
- Phase IV Trials – looks at the long term safety and effectiveness of a new treatment.
- Benefits of Taking Part in Clinical Trials
- High-quality cancer care
- Access to new treatments or new drugs
- Close monitoring of your health for any side effects
- A chance to help others and improve cancer treatment
- Some portion of treatment may be paid by the clinical trial
- Partnership with Seattle Cancer Care Alliance
- MultiCare Regional Cancer Center is a network affiliate of the Seattle Cancer Care Alliance (SCCA). Our patients have access to the world-renowned clinical trials the SCCA offers, while still staying comfortably close to home. One other large aspect of the SCCA affiliation is the ability for physicians to consult with other experts in the field as needed and collaborate together on providing the best care.
The Cancer Center received special recognition for our commitment to placing patients in clinical trials, our involvement in the community in early detection and prevention of cancer and our continued commitment to improve the care patients receive.
- Enhanced Clinical Trials Program
- The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) has qualified seven sites from three of its member institutions (Seattle Cancer Care Alliance, Fox Chase Cancer Center and University of Alabama at Birmingham) as part of its Affiliate Research Project (ARP).
One of those qualified sites is MultiCare Health System's Regional Cancer Center, with direction from Principal Investigator John A. Keech Jr., DO, FACOI. Patients will have access to the most innovative and cutting-edge therapies available, and in so doing they will be making an important contribution to the global fight against cancer.
- A Commitment to Research
- Since 1983, the MultiCare Regional Cancer Center has been involved with cancer research as part of the Community Clinical Oncology Program (CCOP).
The CCOP program is funded by the National Cancer Institute in order to bring the advantages of major clinical research studies closer to home. The Northwest CCOP is one of 62 such programs in the United States and is comprised of 12 hospitals and more than 50 physicians.
- More Information about Research and Clinical Trials
- See a list of clinical trials for various cancers